Quantcast

Latest Catheter ablation Stories

2010-05-13 09:36:00

DIAMOND BAR, California, May 13, 2010 /PRNewswire/ -- Biosense Webster, Inc. will underline its leadership position in the electrophysiology market and underscore its commitment to electrophysiologists and their catheter ablation practices at the 2010 Heart Rhythm Meeting. Heart Rhythm is the most important scientific meeting in the field of Electrophysiology and will be held in Denver, CO, USA from May 12th to 15th. This year, Biosense Webster, Inc. will be showcasing its cutting...

2010-05-13 05:00:00

ST. LOUIS, May 13 /PRNewswire-FirstCall/ -- Stereotaxis' (Nasdaq: STXS) safety and efficacy in the treatment of patients with complex arrhythmias such as atrial fibrillation, ventricular tachycardia, and congenital heart defects will be featured prominently in the scientific program of the 31st Annual Heart Rhythm Scientific Sessions in Denver, Colorado. Eight podium presentations and eight posters will underscore the broad clinical leadership that Stereotaxis has achieved in the...

2010-05-04 17:37:00

ST. LOUIS, May 4 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) today updates progress on a global multi-center clinical study on ventricular tachycardia treatment outcomes by using the company's proprietary Niobe® Magnetic Navigation System. Ventricular tachycardia (VT) is a life-threatening arrhythmia because it may lead to ventricular fibrillation, asystole, and sudden death. VT is one of the most challenging arrhythmias facing electrophysiologists due to...

2010-05-04 09:47:00

WALTHAM, Mass., May 4 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Medtronic could see its heart valve and surgical ablation market shares increase if the company completes its recently announced acquisition of ATS Medical. ATS Medical's device offering is an obvious complement to Medtronic's portfolio; ATS Medical's key product lines overlap with two areas in which Medtronic is seeking to expand its market...

2010-04-21 07:48:00

WALTHAM, Mass., April 21 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, specialty radiofrequency catheters will drive growth in the European catheter market and support the use of catheter ablation as a treatment for atrial fibrillation. According to MRG's new European Markets for Electrophysiology Mapping and Ablation Devices 2010 report, specialty radiofrequency ablation catheter use will grow at a compound...

2010-04-08 12:30:00

WATERLOO, Belgium, April 8, 2010 /PRNewswire/ -- Biosense Webster announces that this week it has obtained its first Ethics Committee approval for the CLARITY study, comparing the 1-year efficacy, safety and efficiency of CARTO(R) 3 System-guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) Catheter versus fluoroscopy-guided radiofrequency ablation using the Pulmonary Vein Ablation Catheter(R) (PVAC(R), Ablation Frontiers, Medtronic) in patients with paroxysmal atrial...

2010-04-08 09:00:00

WATERLOO, Belgium/>, April 8, 2010/> /PRNewswire/ -- Biosense Webster announces that this week it has obtained its first Ethics Committee approval for the CLARITY study, comparing the 1-year efficacy, safety and efficiency of CARTO(R) 3 System-guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) Catheter versus fluoroscopy-guided radiofrequency ablation using the Pulmonary Vein Ablation Catheter(R) (PVAC(R), Ablation Frontiers, Medtronic) in patients with paroxysmal atrial...

2010-03-11 10:50:00

WASHINGTON, March 11 /PRNewswire/ -- As reported in today's Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the over-zealous marketing tactics and incentives by manufacturers of expensive medical devices which are not approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrial fibrillation are likely to be influencing doctors' and hospitals' decisions about treatment for their patients' heart conditions....

2010-02-21 13:15:12

Gene associated with atrial fibrillation in younger patients without known risk factors An international research team has identified a common gene variant associated with a form of the irregular heartbeat called atrial fibrillation. In their report in the journal Nature Genetics, being published online, the investigators describe finding that variations affecting a protein that may help control the heart's electrical activity appear to increase the risk of what is called lone atrial...

2010-01-26 16:01:45

Catheter treatment works dramatically better than drugs for common heart rhythm disorder Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Medical Association (JAMA). One year after undergoing a treatment called catheter ablation, 66 percent of patients with an irregular heartbeat called atrial fibrillation (A-Fib) were free...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related